Autoimmune Disease Therapeutics to 2016

  • May 2012
  • -
  • Greystone Research Associates

As a group, autoimmune diseases represent one of the most intractable families of conditions facing medical science. The complexities and genetic underpinnings of the human immune response result in a set of disease targets that are at once physiologically ubiquitous and highly individualized. Until recently, autoimmune disease patients were given little hope for an effective treatment. But the convergence an of improved understanding of autoimmune disease mechanisms and the availability of recombinant cytokines has led to systemic treatments that, while not devoid of side effects, have demonstrated the ability to control autoimmune reactions in a significant number of patients. A number of potentially important pipeline drugs hold the promise of future improvements in outcomes for autoimmune disease patients. This study analyzes current autoimmune therapeutics and assesses the next-generation of candidates and their probable impact on treatment options and the competitive landscape.

Highlights

• Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential
• Assesses existing and evolving immune disease mechanisms and treatment strategies
• Analyzes more than two dozen existing and emerging autoimmune disease targets and target-specific therapeutic drug products
• Evaluates regional and global opportunities for autoimmune therapeutics
• Provides market data and forecasts for six major autoimmune disease segments to 2016

Table Of Contents

Autoimmune Disease Therapeutics to 2016
Executive Summary

Autoimmune Therapeutics Segment Dynamics

Sector Market Dynamics
Patient Demographics and Growth
Chronic Disease and Self-administration
Managed Care and Prescribing Trends
Factors Limiting Growth
Industry Alignment and Competitive Landscape

Autoimmune Therapeutic Market Assessments

Arthritis
Disease Forms and Immune Mechanisms
Therapeutic Strategies
Disease Demographics and Growth
Key Approved Therapies
Development-stage Candidate Assessment
Market Factors
Commercial Outlook and Forecasts

Crohn's Disease
Disease Incidence and Demographics
Current Generation Treatment Options
Therapies in Development
Market Factors
Commercial Outlook and Forecasts

Diabetes
Restoring Islet Cell Function
Therapies in Development
Commercial Outlook and Forecasts

Lupus
The Ongoing Unmet Need
Pipeline Candidates - A Ray of Hope
Market Factors
The Potential for a Lupus-specific Therapy
Commercial Outlook and Forecasts

Multiple Sclerosis
Disease Mechanisms and Therapeutic Strategies
The Market Opportunity
Competitive Landscape
Development-stage Candidate Assessment
Market Factors
Commercial Outlook and Forecasts

Psoriasis
Therapeutic Options and Expanded Indications
Prescribing Trends and Drug Efficacy
Market Sector Factors
Development-stage Candidate Assessment
Commercial Outlook and Forecasts

Market Factors
Risk Factors
Clinical Trial Factors
Product Issues

Autoimmune Therapeutics - Company Profile

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Psoriasis Therapeutics Market 2015-2019

Global Psoriasis Therapeutics Market 2015-2019

  • $ 3 000
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Psoriasis and Its Types Psoriasis is a common immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes buildup of thick white, red, or silvery patches of skin. It alters ...

Global Ankylosing Spondylitis Market 2015-2019

Global Ankylosing Spondylitis Market 2015-2019

  • $ 3 000
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About Ankylosing Spondylitis Ankylosing spondylitis is a subtype of spondylarthropathy. The primary symptoms of the disease are inflammatory spinal pain with subsequent limitation of spine mobility and ...

Women’s Health - Assessing the Need for a Targeted and Specialized Approach

Women’s Health - Assessing the Need for a Targeted and Specialized Approach

  • $ 2 995
  • Industry report
  • January 2015
  • by CBR Pharma Insights

Women’s Health - Assessing the Need for a Targeted and Specialized Approach Summary Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing ...


Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • March 2015
    8 pages
  • Diabetes Mellit...  

  • United States  

View report >

Pathology Description in the US

  • March 2015
    8 pages
  • Diabetes Mellit...  

  • United States  

View report >

Pathology Description in the US

  • March 2015
    8 pages
  • Diabetes Mellit...  

  • United States  

View report >

Related Market Segments :

Autoimmune Disease

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.